Technology | Magnetic Resonance Imaging (MRI) | April 25, 2016

Siemens Announces FDA Clearance of SMS, GOBrain Neuro MRI Applications

New applications help dramatically reduce MRI brain exam times

Siemens, FDA clearance, SMS, GOBrain, MRI applications

Siemens' Simultaneous Multi-Slice application acquires MR images simultaneously as opposed to sequentially, reducing 2-D acquisition times by as much as a factor of 8.

April 25, 2016 — Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared two new magnetic resonance imaging (MRI) applications – Simultaneous Multi-Slice (SMS) and GOBrain – designed to dramatically reduce the time required for MRI examinations of the brain.

Shorter scans are increasingly important at a time when brain scans account for approximately 1 out of every 4 MRI examinations, and when the number of brain MRI exams is expected to swell to 45 million worldwide this year.

Using an innovative technique that acquires MR images simultaneously as opposed to sequentially, Siemens’ new SMS application reduces 2-D acquisition times by as much as a factor of 8. Using SMS, physicians can reduce the length of MRI brain examinations, which can vary significantly, to times compatible with the clinical routine (e.g., up to 68 percent for diffusion tensor imaging, or DTI) and bring clinical relevance to advanced neurological applications. SMS can be used in the treatment of patients who possess limited tolerance for longer scan times, including pediatric or geriatric patients. In brain surgery cases, SMS may facilitate surgical mapping and improve efficiency in the OR.

Enabling clinically validated brain examinations in just five minutes, the new GOBrain application allows acquisition of clinically essential image orientations and contrasts with a single button-push. The technology is backed by Siemens’ high-channel density coils and the company’s MRI scanning software DotGO. GOBrain helps improve patient throughput and potentially reduce costs per scan. Shorter scan times, which are better tolerated by patients, can help curb lengthy and potentially expensive rescans as well as potentially reduce sedation.

The SMS application is available on Siemens’ Magnetom Aera 1.5T, Magnetom Skyra 3T, and Magnetom Prisma and Prisma Fit 3T MRI systems.

The GOBrain application is featured on the Magnetom Aera and Magnetom Skyra systems.

For more information: www.usa.healthcare.siemens.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...